Showing 121-140 of 387 for: Cochrane Systematic Reviews > Gynecologic 
- Fluoride for treating postmenopausal osteoporosis
Cochrane Systematic Reviews, 23-Oct-2000
Osteoporosis is a condition that results in an increased risk of fractures due to the reduction of bone volume, which is caused by an imbalance between bone formation and bone resorption. Because of this property, fluoride has been used for over 30 years
- Follicular flushing during oocyte retrieval in assisted reproductive techniques
Cochrane Systematic Reviews, 26-Apr-2018
Follicular aspiration under transvaginal ultrasound guidance is routinely performed as part of assisted reproductive technology (ART) to retrieve oocytes for in vitro fertilisation (IVF). However, controversy as to whether follicular flushing following as
- Follow‐up strategies for women treated for early breast cancer
Cochrane Systematic Reviews, 27-May-2016
Follow-up examinations are commonly performed after primary treatment for women with breast cancer. They are used to detect recurrences at an early (asymptomatic) stage. This is an update of a Cochrane review first published in 2000.
- Frameless versus classical intrauterine device for contraception
Cochrane Systematic Reviews, 14-Apr-2008
The frameless intrauterine device (IUD) dispenses with the frame in the classical IUD and holds the device in the uterus by anchoring one end of a nylon thread in the fundal myometrium, to which copper sleeves are attached.
- FSH replaced by low-dose hCG in the late follicular phase versus continued FSH for assisted reproductive techniques
Cochrane Systematic Reviews, 28-Feb-2013
During controlled ovarian hyperstimulation (COH) follicle-stimulating hormone (FSH) is frequently used for several days to achieve follicular development. FSH is a relatively expensive drug, substantially contributing to the total expenses of assisted rep
- Gonadotrophin therapy for ovulation induction in subfertility associated with polycystic ovary syndrome
Cochrane Systematic Reviews, 24-Aug-2015
Approximately 15% of women with PCOS remain anovulatory despite treatment with oral anti-oestrogen medications such as clomiphene citrate. In addition, about half of women with PCOS ovulating on anti-oestrogen treatment fail to conceive. Gonadotrophin sti
- Gonadotrophin‐releasing hormone agonist protocols for pituitary suppression in assisted reproduction
Cochrane Systematic Reviews, 9-Nov-2015
Gonadotrophin-releasing hormone agonists (GnRHa) are commonly used in assisted reproduction technology (ART) cycles to prevent a luteinising hormone surge during controlled ovarian hyperstimulation (COH) prior to planned oocyte retrieval, thus optimising
- Gonadotrophin-releasing hormone analogue as an adjunct to gonadotropin therapy for clomiphene-resistant polycystic ovarian syndrome
Cochrane Systematic Reviews, 17-Jul-2008
Elevation of endogenous LH levels may result in premature luteinization. This may also be associated with the increased rate of spontaneous abortion. Gonadotropin releasing hormone analogue (GnRHa) used prior to human menopausal gonadotropin (hMG/FSH) adm
- Gonadotrophin‐releasing hormone analogues for endometriosis: bone mineral density
Cochrane Systematic Reviews, 20-Oct-2003
Gonadotrophin-releasing hormone analogues (GnRHas) are generally well tolerated, and are effective in relieving the symptoms of endometriosis (Prentice 2003). Unfortunately the low oestrogen state that they induce is associated with adverse effects includ
- Gonadotrophin-releasing hormone analogues for pain associated with endometriosis
Cochrane Systematic Reviews, 16-Mar-2010
Endometriosis is a common gynaecological condition that frequently presents with the symptom of pain. The precise pathogenesis (mode of development) of endometriosis is unclear but it is evident that endometriosis arises by the dissemination of endometriu
- Gonadotrophin-releasing hormone analogues for pain associated with endometriosis
Cochrane Systematic Reviews, 1-Nov-2010
Endometriosis is a common gynaecological condition, characterised by the presence of endometrial tissue in sites other than the uterine cavity (excluding adenomyosis) that frequently presents with pain. The gonadotrophin-releasing hormone analogues (GnRHa
- Gonadotrophin‐releasing hormone antagonists for assisted reproductive technology
Cochrane Systematic Reviews, 29-Apr-2016
Gonadotrophin-releasing hormone (GnRH) antagonists can be used to prevent a luteinizing hormone (LH) surge during controlled ovarian hyperstimulation (COH) without the hypo-oestrogenic side-effects, flare-up, or long down-regulation period associated with
- Gonadotropin‐releasing hormone agonist versus HCG for oocyte triggering in antagonist‐assisted reproductive technology
Cochrane Systematic Reviews, 31-Oct-2014
Human chorionic gonadotropin (HCG) is routinely used for final oocyte maturation triggering in in vitro fertilisation (IVF)/intracytoplasmic sperm injection (ICSI) cycles, but the use of HCG for this purpose may have drawbacks. Gonadotropin-releasing horm
- Growth hormone for in vitro fertilisation (IVF)
Cochrane Systematic Reviews, 22-Nov-2021
In an effort to improve outcomes of in vitro fertilisation (IVF) cycles, the use of growth hormone (GH) has been considered as adjuvant treatment in ovarian stimulation. Improving the outcomes of IVF is especially important for women with infertility who
- Herbal preparations for uterine fibroids
Cochrane Systematic Reviews, 30-Apr-2013
Uterine fibroids are the most common non-malignant growths in women of childbearing age. They are associated with heavy menstrual bleeding and subfertility. Herbal preparations are commonly used as alternatives to surgical procedures.
- High dose rate versus low dose rate intracavity brachytherapy for locally advanced uterine cervix cancer
Cochrane Systematic Reviews, 9-Oct-2014
This is an updated version of the original Cochrane review published in 2010 (Issue 7).
- High‐dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with early poor prognosis breast cancer
Cochrane Systematic Reviews, 20-May-2016
Overall survival rates are disappointing for women with early poor prognosis breast cancer. Autologous transplantation of bone marrow or peripheral stem cells (in which the woman is both donor and recipient) has been considered a promising technique becau
- High‐dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with metastatic breast cancer
Cochrane Systematic Reviews, 20-Jul-2005
Although metastatic breast cancer is often responsive to conventional chemotherapy, it remains ultimately incurable. Autologous transplantation of bone marrow or peripheral stem cells (in which the patient is both donor and recipient) has been considered
- Hormonal contraceptives for contraception in overweight or obese women
Cochrane Systematic Reviews, 11-Aug-2016
Obesity has reached epidemic proportions around the world. Effectiveness of hormonal contraceptives may be related to metabolic changes in obesity or to greater body mass or body fat. Hormonal contraceptives include oral contraceptives (OCs), injectables,
- Hormonal therapy in advanced or recurrent endometrial cancer
Cochrane Systematic Reviews, 1-Apr-2015
Endometrial cancer is a cancer of the lining of the womb and worldwide is the seventh most common cancer in women. Treatment with hormones is thought to be beneficial in patients with endometrial cancer.
